This report contains market size and forecasts of Viral Vector Development Service in Global, including the following market information:
Global Viral Vector Development Service Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Viral Vector Development Service market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Vector Development Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector Development Service Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Viral Vector Development Service Market Segment Percentages, By Type, 2020 (%)
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
China Viral Vector Development Service Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Viral Vector Development Service Market Segment Percentages, By Application, 2020 (%)
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
Global Viral Vector Development Service Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Viral Vector Development Service Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Viral Vector Development Service Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Viral Vector Development Service Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Viral Vector Development Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vector Development Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector Development Service Overall Market Size
2.1 Global Viral Vector Development Service Market Size: 2021 VS 2027
2.2 Global Viral Vector Development Service Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vector Development Service Players in Global Market
3.2 Top Global Viral Vector Development Service Companies Ranked by Revenue
3.3 Global Viral Vector Development Service Revenue by Companies
3.4 Top 3 and Top 5 Viral Vector Development Service Companies in Global Market, by Revenue in 2020
3.5 Global Companies Viral Vector Development Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vector Development Service Players in Global Market
3.6.1 List of Global Tier 1 Viral Vector Development Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vector Development Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vector Development Service Market Size Markets, 2021 & 2027
4.1.2 Retroviral Vectors
4.1.3 Lentiviral Vectors
4.1.4 Adenoviral Vectors
4.1.5 Adeno-associated Viral Vectors
4.1.6 Others Viral Vectors
4.2 By Type - Global Viral Vector Development Service Revenue & Forecasts
4.2.1 By Type - Global Viral Vector Development Service Revenue, 2016-2021
4.2.2 By Type - Global Viral Vector Development Service Revenue, 2022-2027
4.2.3 By Type - Global Viral Vector Development Service Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vector Development Service Market Size, 2021 & 2027
5.1.2 Pharmaceutical Manufacturers
5.1.3 Biotechnology Companies
5.1.4 Research Institutes
5.2 By Application - Global Viral Vector Development Service Revenue & Forecasts
5.2.1 By Application - Global Viral Vector Development Service Revenue, 2016-2021
5.2.2 By Application - Global Viral Vector Development Service Revenue, 2022-2027
5.2.3 By Application - Global Viral Vector Development Service Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Viral Vector Development Service Market Size, 2021 & 2027
6.2 By Region - Global Viral Vector Development Service Revenue & Forecasts
6.2.1 By Region - Global Viral Vector Development Service Revenue, 2016-2021
6.2.2 By Region - Global Viral Vector Development Service Revenue, 2022-2027
6.2.3 By Region - Global Viral Vector Development Service Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Viral Vector Development Service Revenue, 2016-2027
6.3.2 US Viral Vector Development Service Market Size, 2016-2027
6.3.3 Canada Viral Vector Development Service Market Size, 2016-2027
6.3.4 Mexico Viral Vector Development Service Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Viral Vector Development Service Revenue, 2016-2027
6.4.2 Germany Viral Vector Development Service Market Size, 2016-2027
6.4.3 France Viral Vector Development Service Market Size, 2016-2027
6.4.4 U.K. Viral Vector Development Service Market Size, 2016-2027
6.4.5 Italy Viral Vector Development Service Market Size, 2016-2027
6.4.6 Russia Viral Vector Development Service Market Size, 2016-2027
6.4.7 Nordic Countries Viral Vector Development Service Market Size, 2016-2027
6.4.8 Benelux Viral Vector Development Service Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Viral Vector Development Service Revenue, 2016-2027
6.5.2 China Viral Vector Development Service Market Size, 2016-2027
6.5.3 Japan Viral Vector Development Service Market Size, 2016-2027
6.5.4 South Korea Viral Vector Development Service Market Size, 2016-2027
6.5.5 Southeast Asia Viral Vector Development Service Market Size, 2016-2027
6.5.6 India Viral Vector Development Service Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Viral Vector Development Service Revenue, 2016-2027
6.6.2 Brazil Viral Vector Development Service Market Size, 2016-2027
6.6.3 Argentina Viral Vector Development Service Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vector Development Service Revenue, 2016-2027
6.7.2 Turkey Viral Vector Development Service Market Size, 2016-2027
6.7.3 Israel Viral Vector Development Service Market Size, 2016-2027
6.7.4 Saudi Arabia Viral Vector Development Service Market Size, 2016-2027
6.7.5 UAE Viral Vector Development Service Market Size, 2016-2027
7 Players Profiles
7.1 UJIFILM Diosynth Biotechnologies
7.1.1 UJIFILM Diosynth Biotechnologies Corporate Summary
7.1.2 UJIFILM Diosynth Biotechnologies Business Overview
7.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Major Product Offerings
7.1.4 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue in Global (2016-2021)
7.1.5 UJIFILM Diosynth Biotechnologies Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Viral Vector Development Service Major Product Offerings
7.2.4 Sanofi Viral Vector Development Service Revenue in Global (2016-2021)
7.2.5 Sanofi Key News
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Corporate Summary
7.3.2 Spark Therapeutics Business Overview
7.3.3 Spark Therapeutics Viral Vector Development Service Major Product Offerings
7.3.4 Spark Therapeutics Viral Vector Development Service Revenue in Global (2016-2021)
7.3.5 Spark Therapeutics Key News
7.4 UniQure
7.4.1 UniQure Corporate Summary
7.4.2 UniQure Business Overview
7.4.3 UniQure Viral Vector Development Service Major Product Offerings
7.4.4 UniQure Viral Vector Development Service Revenue in Global (2016-2021)
7.4.5 UniQure Key News
7.5 MassBiologics
7.5.1 MassBiologics Corporate Summary
7.5.2 MassBiologics Business Overview
7.5.3 MassBiologics Viral Vector Development Service Major Product Offerings
7.5.4 MassBiologics Viral Vector Development Service Revenue in Global (2016-2021)
7.5.5 MassBiologics Key News
7.6 FinVector
7.6.1 FinVector Corporate Summary
7.6.2 FinVector Business Overview
7.6.3 FinVector Viral Vector Development Service Major Product Offerings
7.6.4 FinVector Viral Vector Development Service Revenue in Global (2016-2021)
7.6.5 FinVector Key News
7.7 Thermo Fisher Scientific (Brammer Bio)
7.7.1 Thermo Fisher Scientific (Brammer Bio) Corporate Summary
7.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
7.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Major Product Offerings
7.4.4 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Revenue in Global (2016-2021)
7.7.5 Thermo Fisher Scientific (Brammer Bio) Key News
7.8 Cell and Gene Therapy Catapult
7.8.1 Cell and Gene Therapy Catapult Corporate Summary
7.8.2 Cell and Gene Therapy Catapult Business Overview
7.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Major Product Offerings
7.8.4 Cell and Gene Therapy Catapult Viral Vector Development Service Revenue in Global (2016-2021)
7.8.5 Cell and Gene Therapy Catapult Key News
7.9 Cobra Biologics
7.9.1 Cobra Biologics Corporate Summary
7.9.2 Cobra Biologics Business Overview
7.9.3 Cobra Biologics Viral Vector Development Service Major Product Offerings
7.9.4 Cobra Biologics Viral Vector Development Service Revenue in Global (2016-2021)
7.9.5 Cobra Biologics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Viral Vector Development Service Market Opportunities & Trends in Global Market
Table 2. Viral Vector Development Service Market Drivers in Global Market
Table 3. Viral Vector Development Service Market Restraints in Global Market
Table 4. Key Players of Viral Vector Development Service in Global Market
Table 5. Top Viral Vector Development Service Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Viral Vector Development Service Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Viral Vector Development Service Revenue Share by Companies, 2016-2021
Table 8. Global Companies Viral Vector Development Service Product Type
Table 9. List of Global Tier 1 Viral Vector Development Service Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vector Development Service Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics